Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ariela Noy, MD
Memorial Sloan Kettering Cancer Center
Study Chair - David M. Aboulafia, MD
Floyd & Delores Jones Cancer Institute at Virginia Mason Medical Center
Study Chair - Lawrence D. Kaplan, MD
University of California, San Francisco
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rebecca and John Moores Ucsd Cancer Center
La Jolla, California, United States
- Ucla Clinical Aids Research and Education (care) Center
Los Angeles, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Ucsf Medical Center at Parnassus
San Francisco, California, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
St Louis, Missouri, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Albert Einstein Cancer Center at Albert Einstein College of Medicine
The Bronx, New York, United States
- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Pennsylvania Oncology Hematology Associates, Incorporated - Philadelphia
Philadelphia, Pennsylvania, United States
- Floyd and Delores Jones Cancer Institute at Virginia Mason Medical Center
Seattle, Washington, United States
- West Virginia University Health Sciences Center - Charleston
Charleston, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2006
- Primary completion
- 31 Jul 2011
- Completion
- 31 Jul 2013
- Last update posted
- 6 Jun 2018
- Registered enrollment
- 34
- Registry id
- NCT00392834
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.